相关实验视频

Updated: Jul 26, 2025

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

帕金森病中的GBA1:变体检测和病原性得分很重要

Carolin Gabbert¹, Susen Schaake¹, Theresa Lüth¹

¹Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, Lübeck, 23538, Germany.

|June 13, 2023

概括

GBA1基因中的遗传变异与帕金森病 (PD) 有关. 牛津纳米孔测序有效地识别了挪威PD患者的GBA1变异,揭示了与疾病风险的关联.

科学领域:

遗传学是一个遗传学.
神经学神经学
生物信息学是一种生物信息学.

背景情况:

葡萄糖脑糖酶 (GBA1) 变体是帕金森病 (PD) 最重要的遗传风险因素.
与PD相关的GBA1变异的精确致病性仍然不完全理解.
GBA1变异的特定种群频率表现出相当大的差异.

研究的目的:

评估牛津纳米孔测序,以确定挪威PD患者和对照中的GBA1变异频率.
审查有关新发现的GBA1变异及其对病原性确定贡献的现有文献.

主要方法:

使用牛津纳米孔网格对462名挪威PD患者和367名对照患者的全长GBA1基因进行测序.
六个分析管道的比较,其中包括两个对齐器 (NGMLR,Minimap2) 和三个变体调用器 (BCFtools,Clair3,Pepper-Margin-Deepvariant).
通过桑格测序确认GBA1变异,并评估其致病性.

主要成果:

NGMLR/Minimap2-BCFtools管道表现出卓越的性能,GBA1变异调用的真正阳性率为95.8%.
鉴定了13种罕见的GBA1变异,其中2种被预测为可能致病性,另有11种具有不确定的意义.
与对照人群相比,患有PD的个体携带常见GBA1变异 (p.L483P或p.N409S) 的几率高4.11倍.

结论:

牛津纳米孔长读测序与NGMLR/Minimap2-BCFtools管道相结合,是调查GBA1变异的有效方法.
需要进一步的研究来阐明GBA1变异的致病性及其对帕金森病发展的具体影响.

关键词:

在GBA中,GBA是GBA.纳米孔测序的测序帕金森病是帕金森氏症的一种疾病.风险因素风险因素风险因素变种变种变种变种

更多相关视频

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.